E-LIB Suche - Ergebnisse für: Italiano, D

1

52P Comparing the genomic landscape of de novo vs recurrent..:

Giugliano, F. ; Douglas, J.R. Dixon ; Dien, A. Tran...
ESMO Open. 9 (2024) - p. 103059 , 2024

Link: https://doi.org/10.1016/..

2

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade ..:

Blay, JY ; Tlemsani, C. ; Toulmonde, M....
European Journal of Cancer. 196 (2024) - p. 113454 , 2024

Link: https://doi.org/10.1016/..

3

52O Resistance to imatinib induced by treatment interruptio..:

Blay, J-Y. ; Devin, Q. ; Duffaud, F....
ESMO Open. 9 (2024) - p. 102442 , 2024

Link: https://doi.org/10.1016/..

4

The CaloCube calorimeter for high-energy cosmic-ray measure..:

Adriani, O. ; Agnesi, A. ; Albergo, S....
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 1061 (2024) - p. 169079 , 2024

Link: https://doi.org/10.1016/..

5

234P Do we need molecular profiling in patients with squamo..:

Smolenschi, C. ; Sharaf, R. ; Hollebecque, A....
Annals of Oncology. 35 (2024) - p. S100-S101 , 2024

Link: https://doi.org/10.1016/..

6

Codon-specific KRAS mutations predict survival in advanced ..:

Boilève, A. ; Rousseau, A. ; Hilmi, M....
ESMO Gastrointestinal Oncology. 3 (2024) - p. 100030 , 2024

Link: https://doi.org/10.1016/..

7

291P Tumor biology, treatment patterns, and survival outcom..:

Turpin, A. ; Pudlarz, T. ; Antoun, L....
Annals of Oncology. 35 (2024) - p. S123 , 2024

Link: https://doi.org/10.1016/..

8

ESMO Recommendations on clinical reporting of genomics test..:

van de Haar, J. ; Roepman, P. ; Andre, F....
Annals of Oncology. , 2024

Link: https://doi.org/10.1016/..

9

Improved nationwide survival of sarcoma patients with a net..:

Blay, J.Y. ; Penel, N. ; Valentin, T....
Annals of Oncology. 35 (2024) 4 - p. 351-363 , 2024

Link: https://doi.org/10.1016/..

10

Current unmet needs in locally advanced (unresectable) or m..:

Schöffski, P. ; Jones, R.L. ; Agulnik, M....
ESMO Open. 9 (2024) 7 - p. 103487 , 2024

Link: https://doi.org/10.1016/..

11

INVESTIGATING THE DISCREPANCIES BETWEEN PET-MEASURED AND MA..:

Gnesin, S. ; Auditore, L. ; Pistone, D...
Physica Medica. 115 (2023) - p. 102827 , 2023

Link: https://doi.org/10.1016/..

12

Regorafenib in patients with relapsed advanced or metastati..:

Le Cesne, A. ; Chevreau, C. ; Perrin, C....
ESMO Open. 8 (2023) 3 - p. 101569 , 2023

Link: https://doi.org/10.1016/..

13

P50 Joint Modelling of Intermediate Longitudinal Biomarkers..:

Linsell, L. ; Paracha, N. ; Grossman, J....
Value in Health. 26 (2023) 12 - p. S12-S13 , 2023

Link: https://doi.org/10.1016/..

14

29P Prevalence of high tumor mutational burden (TMB) in pat..:

Ribeiro, J.T.M.L.M. ; Dien, A. Tran ; Mignot, L....
ESMO Open. 8 (2023) 1 - p. 101253 , 2023

Link: https://doi.org/10.1016/..

15

137P First-in-human results from a phase I dose-escalation ..:

Champiat, S. ; Italiano, A. ; Wagle, N....
Immuno-Oncology and Technology. 20 (2023) - p. 100609 , 2023

Link: https://doi.org/10.1016/..